直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Updates on Director Summary Notices for Decisions on Institution

November 24, 2025

Authored and Edited by William C. Neer; Umber Aggarwal; Forrest A. Jones

On November 20, 2025, Director Squires issued another notice of decisions on institution and amended his first two notices of decisions on institution. All three of these notices contain an updated format, compared to the first two notices, that provides the public with more information about the institution status of post-grant proceedings. Notably, unlike the first two notices that listed cases where institution was denied without specifying the basis of denial, the new notices separate cases into three categories: discretionary denials, cases being reviewed for merit and non-discretionary issue-based denials, and merits-based denials.  

Director Squires assumed the responsibility of issuing institution decisions on October 20, 2025. Additional details about this change may be found in our posts: The New Director Institution Process: USPTO Hour Webinar Provides Updates and First Decision is Released and Recent USPTO Announcements: Proposed Rules to Limit PTAB Challenges and New Institution Review Procedures. In the Director’s first October 31, 2025 summary notice, he stated “[p]ursuant to 35 U.S.C. § 314(a), institution of inter partes review is denied in the following proceedings . . . ,” listing thirteen IPR numbers without further details. The Director issued a similar summary notice on November 6, 2025, denying twenty-one IPR proceedings.

The notices of decisions on institution that published November 20, 2025, follow a similar list format but contain additional details that inform the public about the status of these cases. For example, the newest summary notice groups cases into three categories:

  1. Cases that have been denied based on discretionary considerations;

  2. Cases that have passed discretionary denial review and will be reviewed for merits and non-discretionary considerations; and

  3. Cases that have been denied based on the merits. 

Similarly, the amended October 31, 2025 and amended November 6, 2025 summary notices specify that the originally denied cases were denied for discretionary considerations and add a list of cases that will be reviewed for merits and non-discretionary considerations.

The newest summary notice further includes an asterisk on two cases in which there will be written opinions. These opinions have yet to be issued, and it is unknown whether they will come from the Director or a panel of APJs.

Tags

Patent Trial and Appeal Board (PTAB), institutional decision, discretionary denials

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Reston, VA

Washington, DC

Contacts

William C. Neer
Associate
Washington, DC
+1 202 408 4054
Email
Umber Aggarwal
Associate
Reston, VA
+1 571 203 2423
Email
Forrest A. Jones
Partner
Washington, DC
+1 202 408 4019
Email

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP